This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

Prices will rise in...

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
12 - 14 Nov 2024
Hamburg Congress CenterHamburg, Germany

Tamara Pfaff
Head of Preclinical Development at AiCuris Anti-infective Cures AG
Speaker

Profile

Dr. Tamara Pfaff (Vice President Preclinical Development; Anti-infective Cures AG)

Tamara joined AiCuris in 2010 as Head of Preclinical Drug Safety and steadily increased her responsibilities. She became Senior Director in 2018 and was responsible for all preclinical safety aspects of the AiCuris portfolio. In 2020, she became Head of Preclinical Development. Tamara started her industrial career in 2004 as Head of Laboratory Preclinical Development in the Global Research and Development department of Gruenenthal GmbH and was promoted International Preclinical Project Leader in 2009. She is veterinarian by training and in addition helds a master´s degree in applied toxicology. Tamara is certified pathologist and recognized as a Eurotox-registered toxicologist. She studied at the Universities of Gießen and Surrey, Guildford (UK).

Agenda Sessions

  • AIC468 – A Novel Antisense Oligonucleotide in Clinical Development for Treatment of BKV Infections

    16:15